Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Binglan Zhang, Diyuan Qin, Zeming Mo, et al.
Science China Life Sciences (2016) Vol. 59, Iss. 4, pp. 340-348
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

CAR-T cell therapy: current limitations and potential strategies
Robert C. Sterner, Rosalie M. Sterner
Blood Cancer Journal (2021) Vol. 11, Iss. 4
Open Access | Times Cited: 1781
Current Progress in CAR-T Cell Therapy for Solid Tumors
Shuo Ma, Xinchun Li, Xinyue Wang, et al.
International Journal of Biological Sciences (2019) Vol. 15, Iss. 12, pp. 2548-2560
Open Access | Times Cited: 380
Genetically engineered T cells for cancer immunotherapy
Dan Li, Xue Li, Weilin Zhou, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 205
Nanocomplex‐Mediated In Vivo Programming to Chimeric Antigen Receptor‐M1 Macrophages for Cancer Therapy
Mikyung Kang, Seong Ho Lee, Miji Kwon, et al.
Advanced Materials (2021) Vol. 33, Iss. 43
Closed Access | Times Cited: 128
Cell‐Based Delivery Systems: Emerging Carriers for Immunotherapy
Zhaoting Li, Yixin Wang, Yingyue Ding, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 23
Closed Access | Times Cited: 104
Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments
Gunjan Dagar, Ashna Gupta, Tariq Masoodi, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 102
CAR-T Cell Therapy for Breast Cancer: From Basic Research to Clinical Application
Yu-Huan Yang, Jiawei Liu, Lü Chen, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 6, pp. 2609-2626
Open Access | Times Cited: 81
Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions
Alaa Alnefaie, Sarah Albogami, Yousif A. Asiri, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 74
In Vitro three-dimensional (3D) cell culture tools for spheroid and organoid models
Sang‐Yun Lee, In-Seong Koo, Hyun Ju Hwang, et al.
SLAS DISCOVERY (2023) Vol. 28, Iss. 4, pp. 119-137
Open Access | Times Cited: 69
Dual mRNA co-delivery for in situ generation of phagocytosis-enhanced CAR macrophages augments hepatocellular carcinoma immunotherapy
Zhenmei Yang, Ying Liu, Kun Zhao, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 718-733
Closed Access | Times Cited: 42
Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside
Beibei Zhang, Mengzhe Yang, Weimin Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Immunological nanomaterials to combat cancer metastasis
Yuanbo Pan, Junjie Cheng, Yang Zhu, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 12, pp. 6399-6444
Closed Access | Times Cited: 21
CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity
Yaxian Kong, Jingyao Li, Xia Zhao, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3
The Potential of CAR T Cell Therapy in Pancreatic Cancer
Mehmet Akce, Mohammad Y. Zaidi, Edmund K. Waller, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 117
Magnetic delivery of Fe3O4@polydopamine nanoparticle-loaded natural killer cells suggest a promising anticancer treatment
Liya Wu, Fuqiang Zhang, Zhenhong Wei, et al.
Biomaterials Science (2018) Vol. 6, Iss. 10, pp. 2714-2725
Closed Access | Times Cited: 103
Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells
Yunxin Lai, Jianyu Weng, Xuefeng Wei, et al.
Leukemia (2017) Vol. 32, Iss. 3, pp. 801-808
Closed Access | Times Cited: 93
Nanotechnology-enhanced immunotherapy for metastatic cancer
Peisen Zhang, Junli Meng, Yingying Li, et al.
The Innovation (2021) Vol. 2, Iss. 4, pp. 100174-100174
Open Access | Times Cited: 69
Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer
Dhruv Bansal, Melissa A. Reimers, E Knoche, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 334-334
Open Access | Times Cited: 63
Role of T cells in cancer immunotherapy: Opportunities and challenges
Hossain Ahmed, Aar Rafi Mahmud, Mohd. Faijanur - Rob Siddiquee, et al.
Cancer Pathogenesis and Therapy (2022) Vol. 1, Iss. 2, pp. 116-126
Open Access | Times Cited: 53
Bioorthogonal Equipping CAR-T Cells with Hyaluronidase and Checkpoint Blocking Antibody for Enhanced Solid Tumor Immunotherapy
Yangyang Zhao, Yansong Dong, Shuhan Yang, et al.
ACS Central Science (2022) Vol. 8, Iss. 5, pp. 603-614
Open Access | Times Cited: 49
Biomaterial‐based gene therapy
Yi Yu, Yijun Gao, Liming He, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 35
Advances and prospects of mRNA vaccines in cancer immunotherapy
Yixuan Liu, Qijia Yan, Zhaoyang Zeng, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189068-189068
Closed Access | Times Cited: 14
Car T Cells in Solid Tumors: Overcoming Obstacles
Joselyn Rojas, María P. Díaz, Jim Palmar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4170-4170
Open Access | Times Cited: 12
Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model
Yanan Wang, Jing Wang, Xinyi Yang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Nanoparticles in precision medicine for ovarian cancer: From chemotherapy to immunotherapy
Yuan Li, Yan Gao, Xi Zhang, et al.
International Journal of Pharmaceutics (2020) Vol. 591, pp. 119986-119986
Closed Access | Times Cited: 50
Page 1 - Next Page

Scroll to top